Jennifer C. Burstein's most recent trade in Stoke Therapeutics Inc was a trade of 17,786 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Ms. Jennifer C. Burstein, C.P.A. | Director | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Ms. Jennifer C. Burstein, C.P.A. | Director | 03 Jun 2025 | 29,747 | 29,747 | - | - | Director Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Ms. Jennifer C. Burstein, C.P.A. | Director | 05 Jun 2024 | 7,639 | 7,639 | - | - | Director Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Ms. Jennifer C. Burstein, C.P.A. | Director | 13 Jun 2023 | 19,441 | 19,441 | - | - | Director Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Ms. Jennifer C. Burstein, C.P.A. | Director | 07 Jun 2022 | 21,000 | 21,000 | - | - | Director Stock Option (Right to Buy) |